Concepedia

Meliana Riwanto

MR

Statistics

Publications

15

Citations

2.3K

H-Index

15

Active since

2008

Affiliations

University Hospital of Zurich(Current)

University of Zurich

Swiss Integrative Center for Human Health

AstraZeneca (India)

Novartis (Switzerland)

Meliana Riwanto is an author at University Hospital of Zurich specializing in medicine, cardiovascular disease, and pharmacology.

Publications per year

2008–2016

15

Publications

15

Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease

Christian Besler, Kathrin Heinrich, Lucia Rohrer et al. · Journal of Clinical Investigation · 2011 · 530 citations

, , +16

Altered Activation of Endothelial Anti- and Proapoptotic Pathways by High-Density Lipoprotein from Patients with Coronary Artery Disease

Meliana Riwanto, Lucia Rohrer, Bernd Roschitzki et al. · Circulation · 2013 · 333 citations · Full text

, , +16

Characterization of Levels and Cellular Transfer of Circulating Lipoprotein-Bound MicroRNAs

Jasmin Wagner, Meliana Riwanto, Christian Besler et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2013 · 319 citations · Full text

, , +15

Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex

Ying Huang, Zhiping Wu, Meliana Riwanto et al. · Journal of Clinical Investigation · 2013 · 272 citations

, , +17

The Natural Product Cyclomarin Kills Mycobacterium Tuberculosis by Targeting the ClpC1 Subunit of the Caseinolytic Protease

E. Schmitt, Meliana Riwanto, Vasan K. Sambandamurthy et al. · Angewandte Chemie International Edition · 2011 · 199 citations

, , +6

1–5 of 15